Fennec Pharmaceuticals Inc.(FENC)
Pharmaceuticals, Biotechnology & Life Sciences
Specialty Pharma
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-02 | Raykov Rosty Other | Sale | -9,599 | -0.57%1,661,077 | $10.41 | $99,926 | View SEC filing | |
| 2026-06-02 | Raykov Rosty Director | Sale | -9,747 | -0.58%1,670,676 | $9.62 | $93,766 | View SEC filing | |
| 2026-05-12 | RALLIS CHRIS A Director | Sale | -8,346 | -3.32%243,077 | $7.04 | $58,756 | View SEC filing | |
| 2026-05-01 | Raykov Rosty Director | Sale | -10,781 | -0.64%1,680,423 | $6.47 | $69,753 | View SEC filing | |
| 2026-04-02 | Raykov Rosty Director | Sale | -10,946 | -2.76%385,640 | $6.31 | $69,069 | View SEC filing | |
| 2026-03-03 | Raykov Rosty Director | Sale | -10,079 | -2.61%375,780 | $8.36 | $84,260 | View SEC filing | |
| 2026-02-02 | Raykov Rosty Director | Sale | -10,349 | -2.72%370,261 | $7.76 | $80,308 | View SEC filing | |
| 2026-01-05 | Raykov Rosty Director | Sale | -10,312 | -2.79%359,804 | $7.60 | $78,371 | View SEC filing | |
| 2025-12-29 | Southpoint Capital Advisors LP 10% Owner | Sale | -1,000,000 | -26.70%2,744,741 | $7.50 | $7,500,000 | View SEC filing | |
| 2025-12-05 | Raykov Rosty Director | Sale | -10,000 | -2.78%349,310 | $7.54 | $75,400 | View SEC filing | |
| 2025-11-20 | Southpoint Capital Advisors LP 10% Owner | Sale | -19,341 | -0.51%3,744,741 | $8.79 | $170,048 | View SEC filing | |
| 2025-11-17 | Southpoint Capital Advisors LP 10% Owner | Sale | -246,018 | -6.13%3,764,082 | $8.27 | $2,035,625 | View SEC filing | |
| 2025-11-06 | Raykov Rosty Director | Sale | -10,000 | -2.75%354,102 | $8.10 | $81,000 | View SEC filing | |
| 2025-10-14 | RALLIS CHRIS A Director | Sale | -1,775 | -0.76%231,423 | $9.24 | $16,401 | View SEC filing | |
| 2025-10-09 | Southpoint Capital Advisors LP 10% Owner | Sale | -67,114 | -1.65%4,010,100 | $9.48 | $636,229 | View SEC filing | |
| 2025-10-06 | Raykov Rosty Director | Sale | -10,000 | -2.75%354,285 | $9.78 | $97,800 | View SEC filing | |
| 2025-09-04 | Raykov Rosty Director | Sale | -10,000 | -3.00%322,870 | $8.92 | $89,200 | View SEC filing | |
| 2025-08-05 | Raykov Rosty Director | Sale | -10,000 | -2.96%327,662 | $8.09 | $80,900 | View SEC filing | |
| 2025-07-07 | RALLIS CHRIS A Director | Sale | -1,119 | -0.48%233,198 | $8.71 | $9,746 | View SEC filing | |
| 2025-07-07 | Raykov Rosty Director | Sale | -10,000 | -2.92%332,454 | $8.61 | $86,100 | View SEC filing | |
| 2025-06-06 | Raykov Rosty Director | Sale | -10,000 | -2.88%337,246 | $7.78 | $77,800 | View SEC filing | |
| 2025-05-19 | Hackman Jeffrey S. Chief Executive Officer | Purchase | +15,000 | +100.00%15,000 | $6.97 | $104,602 | View SEC filing | |
| 2025-05-19 | Raykov Rosty Director | Sale | -16,667 | -4.65%342,038 | $6.78 | $113,002 | View SEC filing | |
| 2025-05-05 | Raykov Rosty Director | Sale | -10,000 | -2.98%325,371 | $6.31 | $63,100 | View SEC filing | |
| 2025-04-11 | RALLIS CHRIS A Director | Sale | -1,409 | -0.60%234,317 | $4.95 | $6,975 | View SEC filing |
1-25 of 80